This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.

Activity Details

18 * ! Sun, 8/1/2010, 2:00 PM - 3:50 PM CC-110 (West)
Bayesian and Adaptive Design Applications in Early Phase Clinical Trials — Topic Contributed Papers
Biopharmaceutical Section , ENAR , Section on Bayesian Statistical Science , Statistical Programmers and Analysts
Organizer(s): Yuehui Wu, GlaxoSmithKline
Chair(s): Bingming Yi, GlaxoSmithKline
2:05 PM Novel Phase I Design for Oncology Research Linda Sun, Merck & Co., Inc. ; Keaven M. Anderson, Merck Research Laboratories ; Lisa Lupinacci, Merck & Co., Inc. ; Yevgen Tymofyeyev, Merck & Co., Inc.
2:25 PM Better Learning About the MTD in Phase I Oncology Trial: A Case Study Implementing Bayesian Design Based on Continuous Reassessment Method Inna Perevozskaya, Pfizer Inc.
2:45 PM Adaptive Designs in Dose-Finding Oncology Drug Combination Trials Yuehui Wu, GlaxoSmithKline ; Bingming Yi, GlaxoSmithKline ; Yanmei Xu, GlaxoSmithKline
3:05 PM Evaluation of Dose-Finding Designs: On the Interplay Between Theory and Simulation Assaf P. Oron, University of Washington ; Peter Hoff, University of Washington
3:25 PM Expect the Unexpected: Bayesian Adaptive Dose-Finding Design in Proof-of-Concept Study Feng Liu, GlaxoSmithKline
3:45 PM Floor Discussion

2010 JSM Online Program Home

For information, contact or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.